{
  "trial_id": "NCT01141712",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, HIV viral load, type of lymphoma, number of prior chemotherapy regimens, response to induction or salvage therapy, bone marrow involvement percentage, cardiac function (left ventricular ejection fraction), hepatic function (bilirubin, ALT, AST levels), renal function (creatinine clearance), pulmonary function (DLCO, FEV1, FVC), CD34+ cell count in stem cell graft, time from mobilization or bone marrow harvest to conditioning therapy, antiretroviral therapy status, Karnofsky performance score, presence of uncontrolled infections, history of prior malignancy, pregnancy status, contraceptive use, prior HCT history, evidence of MDS/AML.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race/ethnicity"
        ],
        [
          "Karnofsky Performance Score",
          "Karnofsky performance score"
        ],
        [
          "Participant Diagnosis",
          "type of lymphoma"
        ],
        [
          "Disease Status",
          "response to induction or salvage therapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "HIV viral load",
        "number of prior chemotherapy regimens",
        "bone marrow involvement percentage",
        "cardiac function (left ventricular ejection fraction)",
        "hepatic function (bilirubin, ALT, AST levels)",
        "renal function (creatinine clearance)",
        "pulmonary function (DLCO, FEV1, FVC)",
        "CD34+ cell count in stem cell graft",
        "time from mobilization or bone marrow harvest to conditioning therapy",
        "antiretroviral therapy status",
        "presence of uncontrolled infections",
        "history of prior malignancy",
        "pregnancy status",
        "contraceptive use",
        "prior HCT history",
        "evidence of MDS/AML"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, HIV viral load, CD4 count, Type of lymphoma, Number of prior chemotherapy regimens, Bone marrow involvement, Cardiac function (ejection fraction), Hepatic function (bilirubin, ALT, AST), Renal function (creatinine clearance), Pulmonary function (DLCO, FEV1, FVC), Karnofsky performance score,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Karnofsky Performance Score",
          "Karnofsky performance score"
        ],
        [
          "Participant Diagnosis",
          "Type of lymphoma"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Disease Status"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "HIV viral load",
        "CD4 count",
        "Number of prior chemotherapy regimens",
        "Bone marrow involvement",
        "Cardiac function (ejection fraction)",
        "Hepatic function (bilirubin, ALT, AST)",
        "Renal function (creatinine clearance)",
        "Pulmonary function (DLCO, FEV1, FVC)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, HIV Viral Load, CD4 Cell Count, Lymphoma Stage, Lymphoma Subtype, Prior Chemotherapy Regimens, Bone Marrow Involvement, Left Ventricular Ejection Fraction, Bilirubin, Alanine Transaminase, Aspartate Transaminase, Creatinine Clearance, Carbon Monoxide Diffusing Capacity, Forced Expiratory Volume in 1 Second, Forced Vital Capacity.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Karnofsky Performance Score",
          "Karnofsky Performance Score"
        ],
        [
          "Participant Diagnosis",
          "Lymphoma Subtype"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Disease Status"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "HIV Viral Load",
        "CD4 Cell Count",
        "Lymphoma Stage",
        "Prior Chemotherapy Regimens",
        "Bone Marrow Involvement",
        "Left Ventricular Ejection Fraction",
        "Bilirubin",
        "Alanine Transaminase",
        "Aspartate Transaminase",
        "Creatinine Clearance",
        "Carbon Monoxide Diffusing Capacity",
        "Forced Expiratory Volume in 1 Second",
        "Forced Vital Capacity"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, Karnofsky performance score, HIV viral load, CD4 count, lymphoma diagnosis, prior chemotherapy regimens, bone marrow involvement, cardiac function (left ventricular ejection fraction), hepatic function (bilirubin, ALT, AST), renal function (creatinine clearance), pulmonary function (DLCO, FEV1, FVC), autologous peripheral stem cell graft characteristics (CD34+ cells/kg).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Karnofsky Performance Score",
          "Karnofsky performance score"
        ],
        [
          "Participant Diagnosis",
          "lymphoma diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Disease Status"
      ],
      "remaining_candidate_features": [
        "HIV viral load",
        "CD4 count",
        "prior chemotherapy regimens",
        "bone marrow involvement",
        "cardiac function (left ventricular ejection fraction)",
        "hepatic function (bilirubin, ALT, AST)",
        "renal function (creatinine clearance)",
        "pulmonary function (DLCO, FEV1, FVC)",
        "autologous peripheral stem cell graft characteristics (CD34+ cells/kg)"
      ]
    }
  }
}